Aggressive behaviours in people with intellectual disabilities: Psychopharmacological treatment;Il trattamento psicofarmacologico del comportamento aggressivo nella persona con disabilità intellettiva

Minerva Psichiatrica

Volumn 46, Issue 1, 2005, Pages 29-33

  La Malfa, G P ^a   Castellani, A ^a   Bertelli, M ^a   Lassi, S ^a  

^a Società Italiana per il Ritardo Mentale SIRM   (Italy)

Author keywords

Aggressive behaviour; Intellectual Disability; Psichopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT; BIOLOGICAL FACTOR; MOOD STABILIZER; NEUROLEPTIC AGENT; TRANQUILIZER;

AGGRESSION; ENVIRONMENTAL FACTOR; HEALTH STATUS; HUMAN; INTELLECTUAL IMPAIRMENT; PSYCHOLOGICAL ASPECT; REVIEW; SOCIAL ASPECT;

EID: 33745361199     PISSN: 03911772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. American Association on Mental Retardation. Mental Retardation. Definitions, Classification and System of Support. 10th ed. Washington: American Association on Mental Retardation; 2002.
2. Dosen A. Day K. Epidemiology, Etiology and Presentation of Mental Illness and Behavior Disorders in Persons with Mental Retardation. In: Dosen A, Day K editors. Treating Mental Illness and Behaviour Disorders in Children and Adults with Mental Retardation. Washington: American Psychiatric Press; 2001. p. 110-36.
3. Dosen A, Day K. Treating Mental Illness and Behaviour Disorders in Children and Adults with Mental Retardation. Washington: American Psychiatric Press; 2001.
4. Reiss S. The prevalence of dual diagnosis in community based day programmes in the Chicago metropolitan area. Am J Ment Retard 1990,94:578-85.
5. Reiss S, Rojahn J. Joint occurrence of depression and aggression in children and adults with mental retardation. J Intellect Disabil Res 1994;37:287-94.
6. Horner RH, Day HM. The effects of response efficiency on functionally equivalent competing behaviors. J Appl Behav Anal 1991;24:719-32.
7. Durand VM, Carr EG. Reducing severe behavior problems among person with dual sensory impairment: an evaluation of a technical assistence model. Journal of the Association for the Severely Handicapped 1987;12:2-10.
8. Szymanski L. Integrative approach to diagnosis of mental disorders in retarded persons. In: Stark J, Melanoscino F, Alberelli N editors. Mental Retardation and Mental Health. New York: Springer-Verlag; 1988. p. 7-39.
9. Borthwick-Duffy SA. Prevalence of destructive behaviours: a study of aggression, self-injury, and property-destruction. In: Thompson T, Gray DB editors. Destructive behaviour in developmental disabilities. Thousand Oaks, CA: Sage; 1994. p. 57-76.
10. Bernard L, Young AH, Pearson J, Geddes J, O'Brien G. A systematic review of the use of antipsychotics in autism. J Psychopharmacol 2002;16:93-101.
11. La Malfa GP, Conte M, Bertelli M, Fanelli L, Cabras PL. Il comportamento aggressivo nei disturbi psichiatrici. Minerva Psichiatr 2001;142:189-204.
12. Gardner WJ. Aggression and Other Disruptive Bahavioural Challenges. Kingston, NY: NADD Press; 2002.
13. Markowitz P. Pharmacotherapy of impulsivity, aggression and related disorders. In: Hollander E, Stein DJ editors. Impulsivity and aggression. Chichester: John Wiley; 1998. p. 210-25.
14. Murphy DL, Mellow AM, Sunderland T. Strategies for the study of serotonin in humans. In: Coccaro EF, Murphy DL editors. Serotonin in major psychiatric disorders. Washington DC: American Psychiatric Press; 1990. p. 49-75.
15. Coccaro EF, Kavaussi RJ, Herman ME. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality disorders males. Biol Psychiatry 1996;40:157-64.
16. Consensus Conference Società Italiana per il Ritardo Mentale -Utilizzo dei farmaci antipsicotici e stabilizzatori dell'umore nel ritardo mentale. Ital J Psychopathol 2003:9 Suppl: 1-9.
17. McCraken JT, McGough J Shab B, Cronin P, Hong D, Aman MG. Risperidone in children with autism and serious behaviuoral problems. N Engl J Med 2002;347:314-21.
18. Zarcone JR, Hellings JA, Crandall K, Reese RM, Marquis J, Fleming K et al. Effects of risperidone on aberrant behavior of persons with developmental disabilities: I. A double-blind crossover study using multiple measures. Am J Ment Retard 2001;106:525-38.
19. Krishnamoorthy J, King BH. Open-label olanzapine treatment in five preadolescent children. J Child Adolesc Psychopharmacol 1998;8:107-13.
20. Antonacci DJ, de Groot CM. Clozapine treatment in a population of adults with mental retardation. J Clin Psychiatry 2000;61:22-55.
21. Martin A, Koenig K, Scahill L, Bregman J. Open-label quetiapine in the treatment of children and adolescents with autistic disorder. J Child Adolesc Psychopharmacol 1999;9:99-107.
22. Verhoeven WMA, Tuinier S. Pharmacotherapy in Aggressive and Auto-Aggressive Behavior. In: Dosen A, Day K editors. Treating Mental Illness and Behaviour Disorders in Children and Adults with Mental Retardation. Washington: American Psychiatric Press; 2001. p. 54-172.
23. La Malfa GP, Bertelli M, Lassi S, Salvini R, Placidi GF. Uso degli antidepressivi nella persona con disabilità intellettiva: revisione della letteratura. Am J Ment Retard (ed. it.) 2004;2:302-10.
24. Friedman EH. Fluoxetine and aggressive behaviour. Pharmacopsychiatry 1996;29:121.
25. Troisi A, Vicario E, Nuccetelli F, Ciani N, Pasini A. Effects of fluoxetine on aggressive behavior of adult in-patients with mental retardation and epilepsy. Pharmacopsychiatry 1995;28:73-6.
26. Consensus Conference Società Italiana per il Ritardo Mentale. Uso di farmaci antidepressivi e antiansia nella persona con disabilità intellettiva. Ital J Psychopathol [In press].
27. La Malfa GP, Bertelli M, Conte M. Fluvoxamine and aggression in mental retardation. Psychiatr Serv 2001;52:1105.
28. Davanzo PA, Belin TR, Widawski MH, King BH. Paroxetine treatment of aggression and self-injury in persons with mental retardation. Am J Ment Retard 1998;102:427-37.
29. Hellings JA, Kelley LA, Gabrielli WF, Kilgore E, Shah P. Sertraline response in adults with mental retardation and autistic disorder. J Clin Psychiatry 1996; 57:333-6.
30. Verhoeven WM, Tuinier S. The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study. J Intellect Disabil Res 1996;40 (Pt 6):502-8.